Atomistry » Chlorine » PDB 2c5w-2chz » 2c8w
Atomistry »
  Chlorine »
    PDB 2c5w-2chz »
      2c8w »

Chlorine in PDB 2c8w: Thrombin Inhibitors

Enzymatic activity of Thrombin Inhibitors

All present enzymatic activity of Thrombin Inhibitors:
3.4.21.5;

Protein crystallography data

The structure of Thrombin Inhibitors, PDB code: 2c8w was solved by N.Howard, C.Abell, W.Blakemore, R.Carr, G.Chessari, M.Congreve, S.Howard, H.Jhoti, C.W.Murray, L.C.A.Seavers, R.L.M.Van Montfort, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 70.71 / 1.96
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 70.579, 71.906, 72.200, 90.00, 100.42, 90.00
R / Rfree (%) 16.4 / 21.9

Other elements in 2c8w:

The structure of Thrombin Inhibitors also contains other interesting chemical elements:

Sodium (Na) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Thrombin Inhibitors (pdb code 2c8w). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Thrombin Inhibitors, PDB code: 2c8w:

Chlorine binding site 1 out of 1 in 2c8w

Go back to Chlorine Binding Sites List in 2c8w
Chlorine binding site 1 out of 1 in the Thrombin Inhibitors


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Thrombin Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Cl1249

b:14.3
occ:1.00
CL33 B:C7M1249 0.0 14.3 1.0
C32 B:C7M1249 1.7 12.9 1.0
C34 B:C7M1249 2.7 16.7 1.0
C31 B:C7M1249 2.7 13.3 1.0
H63 B:C7M1249 2.9 15.3 1.0
H62 B:C7M1249 2.9 13.3 1.0
CA B:GLY226 3.5 11.6 1.0
O B:PHE227 3.5 11.0 1.0
O B:TRP215 3.6 12.4 1.0
N B:PHE227 3.6 11.2 1.0
CG1 B:VAL213 3.7 7.9 1.0
C B:GLY226 3.8 11.2 1.0
CZ B:TYR228 3.9 10.6 1.0
OH B:TYR228 3.9 12.2 1.0
C35 B:C7M1249 4.0 15.4 1.0
C30 B:C7M1249 4.0 13.9 1.0
C B:TRP215 4.1 14.8 1.0
CE1 B:TYR228 4.1 11.2 1.0
CB B:ALA190 4.1 9.5 1.0
CE2 B:TYR228 4.2 12.9 1.0
C B:PHE227 4.3 11.4 1.0
N B:TRP215 4.3 11.3 1.0
OD1 B:ASP189 4.3 12.0 1.0
N B:SER214 4.3 10.2 1.0
O B:HOH2332 4.5 13.2 1.0
C36 B:C7M1249 4.5 15.4 1.0
CA B:PHE227 4.5 9.3 1.0
CA B:VAL213 4.6 8.8 1.0
CA B:TRP215 4.6 12.4 1.0
N B:GLY216 4.7 15.0 1.0
CB B:VAL213 4.7 9.0 1.0
CD1 B:TYR228 4.7 10.6 1.0
CD2 B:TYR228 4.8 9.4 1.0
N B:GLY226 4.8 13.8 1.0
O B:GLY226 4.9 11.0 1.0
C B:VAL213 4.9 8.8 1.0
H64 B:C7M1249 4.9 15.8 1.0
CA B:GLY216 4.9 13.7 1.0
C B:SER214 4.9 11.2 1.0

Reference:

N.Howard, C.Abell, W.Blakemore, G.Chessari, M.Congreve, S.Howard, H.Jhoti, C.W.Murray, L.C.A.Seavers, R.L.M.Van Montfort. Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors J.Med.Chem. V. 49 1346 2006.
ISSN: ISSN 0022-2623
PubMed: 16480269
DOI: 10.1021/JM050850V
Page generated: Thu Jul 10 21:41:55 2025

Last articles

Mg in 6O3P
Mg in 6O2R
Mg in 6O2Q
Mg in 6O36
Mg in 6O2P
Mg in 6O1V
Mg in 6O0J
Mg in 6O1E
Mg in 6O0G
Mg in 6NYY
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy